Frontlight ResearchEarly access
Trial site
Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego W Lodzi SPZOZ
- 11running trials
- 1closed trial
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Heart failure6 trials
- Obesity3 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Psoriasis1 trial
- Phase
- Phase 311 trials
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting4 trials
- Completed1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Amgen Inc.1 trial
- AstraZeneca1 trial
- AstraZeneca AB1 trial
- Cytokinetics1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A study to test if SRSD107 prevents venous thromboembolism events and how safe it is
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Obesity3 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026